Valbiotis SAS (ALVAL) - Total Liabilities

Latest as of December 2025: €7.43 Million EUR ≈ $8.68 Million USD

Based on the latest financial reports, Valbiotis SAS (ALVAL) has total liabilities worth €7.43 Million EUR (≈ $8.68 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Valbiotis SAS equity growth rate to track the company's year-over-year net asset growth rate.

Valbiotis SAS - Total Liabilities Trend (2015–2025)

This chart illustrates how Valbiotis SAS's total liabilities have evolved over time, based on quarterly financial data. See Valbiotis SAS (ALVAL) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Valbiotis SAS Competitors by Total Liabilities

The table below lists competitors of Valbiotis SAS ranked by their total liabilities.

Company	Country	Total Liabilities
BRIDGETEC Corp KQ:064480	Korea	₩13.08 Billion
Sin Heng Chan (Malaya) Bhd KLSE:4316	Malaysia	RM210.87 Million
Spacenet Enterprises India Limited NSE:SPCENET	India	Rs496.11 Million
Patentus SA WAR:PAT	Poland	zł27.07 Million
Prefab Bucures RO:PREH	Romania	RON45.03 Million
Asia Poly Holdings Bhd KLSE:0105	Malaysia	RM77.39 Million
Muar Ban Lee Group Bhd KLSE:5152	Malaysia	RM103.00 Million
Alpine Summit Energy Partners Inc NASDAQ:ALPS	USA	$12.97 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Valbiotis SAS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Valbiotis SAS stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.85	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	1.57	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.52	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Valbiotis SAS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Valbiotis SAS (2015–2025)

The table below shows the annual total liabilities of Valbiotis SAS from 2015 to 2025.

Year	Total Liabilities	Change
2025-12-31	€7.43 Million ≈ $8.68 Million	-19.60%
2024-12-31	€9.24 Million ≈ $10.80 Million	-32.62%
2023-12-31	€13.71 Million ≈ $16.03 Million	-1.08%
2022-12-31	€13.86 Million ≈ $16.20 Million	-2.72%
2021-12-31	€14.25 Million ≈ $16.66 Million	+2.29%
2020-12-31	€13.93 Million ≈ $16.28 Million	+104.63%
2019-12-31	€6.81 Million ≈ $7.96 Million	+51.35%
2018-12-31	€4.50 Million ≈ $5.26 Million	+76.15%
2017-12-31	€2.55 Million ≈ $2.98 Million	+103.43%
2016-12-31	€1.25 Million ≈ $1.47 Million	+16.31%
2015-12-31	€1.08 Million ≈ $1.26 Million	--

About Valbiotis SAS

PA:ALVAL France Packaged Foods

Market Cap

$21.19 Million

€18.12 Million EUR

Market Cap Rank

#24909 Global

#406 in France

Share Price

€0.77

Change (1 day)

+1.46%

52-Week Range

€0.55 - €1.21

All Time High

€10.54